Loading companies…

Pharmx Technologies Ltd ASX:PHX

0 opened or increased2 held0 reduced or exitedlatest position by manager, past 12 months90 days: 0 increased, 0 reduced. 3 managers in total.

Position history by manager 3 managersSelect a point to see the comment

Opened or increasedHeldReduced or exited Start or end of the position not reported

20252026

31 Oct 2024 to today

Commentary Showing 2 of 7

DateManagerActionSummary

4 Aug 2026Naos Asset ManagementHeldNAOS Asset Management continues to hold Pharmx Technologies because it views the business as mission-critical digital infrastructure backed by strategic shareholders, expanding its product offering with high-margin revenue layers to build a wider business moat. NAOS highlights initial work items agreed under the Sigma Healthcare alliance and strong growth in marketplace volume, which is expected to exceed $100 million within 12 months.

Quarterly Report, price recorded $0.10

The source document link is a Pro feature

31 Mar 2026Naos Asset ManagementHeldNaos Asset Management continues to hold Pharmx Technologies Ltd because the appointment of a Chemist Warehouse director to the board — following Chemist Warehouse's acquisition of a 10% stake with the option to increase to 19.9% — signals a deepening strategic relationship that has the potential to generate significant incremental revenue over time. Naos Asset Management notes that both Chemist Warehouse and entities associated with Dennis Bastas and the Apotex Group are now substantial shareholders with board representation, providing PharmX with two highly strategic investors. The fund highlights recent product launches including a new Marketplace platform and Stockview solution as near-term catalysts.

Monthly Report, price recorded $0.11

The source document link is a Pro feature

5 more comments on PHXPro shows every comment, with a link to each source document.

Upgrade to Pro

First mention by manager

Price recorded at each manager's first comment

Price at first mentionThe share price recorded when each of 3 managers first commented on PHX.

View Pro

Articles

31 Mar 2026PharmX Technologies PHX Fund Manager Commentary and Investment Thesis

About Pharmx Technologies Ltd

Healthcare, Software

PharmX Technologies (ASX:PHX) operates the ordering gateway that underpins Australian pharmacy supply chains, and is a core holding for NAOS Asset Management. In August 2026, NAOS described PharmX as mission-critical digital infrastructure with strategic shareholders, expanding into higher-margin revenue streams and agreeing initial work with Sigma Healthcare. QVG Capital noted most money spent in pharmacies flows through PharmX's gateway, with a strategy to expand into a marketplace. NAOS also highlighted the appointment of a Chemist Warehouse director to PharmX's board. PharmX operates in the Information Technology sector within the Software industry, and Thesis Tracker has captured 7 comments from 4 fund managers, including NAOS and QVG Capital. Headquartered in Sydney, PharmX provides the electronic ordering gateway connecting pharmacies with wholesalers and suppliers, alongside dispensing and point-of-sale software for pharmacies.

Market cap: $59m
Price to earnings: Loss-making
Return on equity: 0.0%
Dividend yield: 0.0%
Price to book: 0.00x
Net margin: 0.0%
52-week range: $0.08 to $0.20

Company figures as of 15 Oct 2026. For information only.

Questions

Who is investing in Pharmx Technologies Ltd (ASX:PHX)?

Fund managers including Naos Asset Management, DMX Asset Management, QVG Capital and NAOS Asset Management have invested in Pharmx Technologies Ltd (ASX:PHX).

What opportunities or catalysts do fund managers highlight for Pharmx Technologies Ltd?

NAOS and QVG highlight PharmX's mission-critical position in pharmacy ordering, the launch of a new marketplace platform, high-margin revenue layering and strategic alignment with Sigma Healthcare and Chemist Warehouse through board representation and new work agreements.

What are the key risks to the Pharmx Technologies Ltd investment thesis, according to fund managers?

The available commentary is positive and does not detail specific risks, though PharmX is a small company whose growth depends on executing its marketplace strategy and maintaining relationships with large pharmacy groups.

What does Pharmx Technologies Ltd (ASX:PHX) do?

PharmX Technologies Ltd. is a Sydney-based software developer founded in 1950. The company operates through two primary segments: Health Services and eCommerce. Its Health Services division delivers dispense and point-of-sale software, hardware, and technical support to Australian pharmacies. The eCommerce segment provides electronic payment solutions, enabling individuals and businesses to settle rent, utilities, local government fees, and commercial obligations securely. PharmX Technologies focuses on professional software infrastructure across these distinct operational categories.

General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.

11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.

Disclaimer Terms of Use Privacy Complaints Contact

Loading…